EMCDDA Home
  • EN
Search

Table TDI-103. All clients entering outpatient treatment by primary drug and age, 2011 or most recent year available

Part (v) All hypnotics and sedatives outpatient clients by country and age

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium031213271428891861187
Bulgaria027381161350050
Czech Republic00043541632032
Denmark032367931061061
Germany1227396138135197670133251337
Estonia:::::::::::
Ireland12464125312411181980198
Greece0310919100657057
Spain10571201011161531092879431944
France11647991081371352067491750
Italy200220313148722049213
Cyprus0203452319019
Latvia318418101117401090109
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary143491072765065
Malta:::::::::::
Netherlands122102959364551545860586
Austria1515151068767067
Poland4::13111::::
Portugal50022275422022
Romania00001100202
Slovenia::::3::::::
Slovakia00308111023023
Finland0215151392965065
Sweden10145234261620432050205
United Kingdom612138326411433364260591253512536
Croatia:95626616:::
Turkey:::::::::::
Norway70427474949331713800380
Total2036091010091152107995824627890187908
 

Notes:

: Indicates no data available.

(1) Data are from 2010.

(2) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(4) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(6) Data are from 1st of April 2010 to 31st March 2011.

(7) In Norway the criteria for selecting and grouping cases are main ICD-10 diagnosis codes F11-F16 and F18-F19.

For more information relative to the treatment centre type, please see Table TDI-7.

See also Table TDI-10 part(iii), part(iv)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Outpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013